KraneShares China [KLIP] vs Sagimet Biosciences [SGMT] Detailed Stock Comparison
KraneShares China
NYSE
Loading...
Sagimet Biosciences
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: KraneShares China wins in 5 metrics, Sagimet Biosciences wins in 5 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | KraneShares China | Sagimet Biosciences | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.45 | -5.03 | Sagimet Biosciences |
| Price-to-Book Ratio | N/A | 1.80 | N/A |
| Debt-to-Equity Ratio | 2.17 | 0.12 | Sagimet Biosciences |
| PEG Ratio | N/A | -0.18 | N/A |
| EV/EBITDA | 5.63 | -2.05 | Sagimet Biosciences |
| Profit Margin (TTM) | 13.92% | 0.00% | KraneShares China |
| Operating Margin (TTM) | N/A | 0.00% | N/A |
| Return on Equity | -32.84% | -37.89% | KraneShares China |
| Return on Assets (TTM) | -5.37% | -25.61% | KraneShares China |
| Free Cash Flow (TTM) | N/A | $-42.44M | N/A |
| 1-Year Return | -10.04% | 69.61% | Sagimet Biosciences |
| Price-to-Sales Ratio (TTM) | 0.00 | N/A | N/A |
| Enterprise Value | $47.78M | $111.83M | Sagimet Biosciences |
| EV/Revenue Ratio | 0.32 | N/A | N/A |
| Revenue per Share (TTM) | $1 | $0 | KraneShares China |
| Earnings per Share (Diluted) | $-0.02 | $-1.86 | KraneShares China |
| Beta (Stock Volatility) | N/A | 3.27 | N/A |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
KraneShares China vs Sagimet Biosciences Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| KraneShares China | -0.21% | 0.73% | 0.76% | 4.35% | 17.02% | 2.98% |
| Sagimet Biosciences | 0.27% | 5.64% | 3.98% | -15.78% | 276.80% | 62.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| KraneShares China | -10.04% | -55.61% | -55.61% | -55.61% | -55.61% | -55.61% |
| Sagimet Biosciences | 69.61% | -54.14% | -54.14% | -54.14% | -54.14% | -54.14% |
News Based Sentiment: KraneShares China vs Sagimet Biosciences
KraneShares China
News based Sentiment: NEUTRAL
The month's events indicate steady operations for KraneShares, with a share consolidation and research publication alongside a neutral 'Hold' rating from Danelfin AI. These developments don't signal major shifts in the company's direction, but demonstrate ongoing management and market engagement.
Sagimet Biosciences
News sentiment data is not available for Sagimet Biosciences at this time.
Performance & Financial Health Analysis: KraneShares China vs Sagimet Biosciences
| Metric | KLIP | SGMT |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $249.31M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 27,920 | 443,270 |
| 90 Day Avg. Volume | 33,377 | 471,207 |
| Last Close | $33.07 | $7.31 |
| 52 Week Range | $27.06 - $37.41 | $1.73 - $11.41 |
| % from 52W High | -11.60% | -35.93% |
| All-Time High | $75.90 (Jan 23, 2023) | $20.71 (Jan 22, 2024) |
| % from All-Time High | -56.43% | -64.70% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.00% |
| Operating Margin (TTM) | N/A | 0.00% |
| Return on Equity (TTM) | -0.33% | -0.38% |
| Debt to Equity (MRQ) | 2.17 | 0.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | N/A | $4.04 |
| Cash per Share (MRQ) | N/A | $3.86 |
| Operating Cash Flow (TTM) | $-8,348,000 | $-54,230,000 |
| Levered Free Cash Flow (TTM) | $-5,663,000 | $-35,545,376 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: KraneShares China vs Sagimet Biosciences
| Metric | KLIP | SGMT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.45 | -5.03 |
| Forward P/E | N/A | -2.05 |
| PEG Ratio | N/A | -0.18 |
| Price to Sales (TTM) | 0.00 | N/A |
| Price to Book (MRQ) | N/A | 1.80 |
| Market Capitalization | ||
| Market Capitalization | $0 | $249.31M |
| Enterprise Value | $47.78M | $111.83M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.32 | N/A |
| Enterprise to EBITDA | 5.63 | -2.05 |
| Risk & Other Metrics | ||
| Beta | N/A | 3.27 |
| Book Value per Share (MRQ) | N/A | $4.04 |
Financial Statements Comparison: KraneShares China vs Sagimet Biosciences
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | KLIP | SGMT |
|---|---|---|
| Revenue/Sales | N/A | $0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | $15.34M |
| Operating Income (EBIT) | N/A | $-19.87M |
| EBITDA | N/A | $-19.87M |
| Pre-Tax Income | N/A | $-18.18M |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | $-18.18M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | KLIP | SGMT |
|---|---|---|
| Cash & Equivalents | N/A | $64.72M |
| Total Current Assets | N/A | $146.07M |
| Total Current Liabilities | N/A | $7.18M |
| Long-Term Debt | N/A | N/A |
| Total Shareholders Equity | N/A | $138.99M |
| Retained Earnings | N/A | $-313.49M |
| Property, Plant & Equipment | N/A | $38,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | KLIP | SGMT |
|---|---|---|
| Operating Cash Flow | N/A | $-16.70M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | $-14.54M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KLIP | SGMT |
|---|---|---|
| Shares Short | N/A | 3.11M |
| Short Ratio | N/A | 5.61 |
| Short % of Float | N/A | 0.11% |
| Average Daily Volume (10 Day) | 27,920 | 443,270 |
| Average Daily Volume (90 Day) | 33,377 | 471,207 |
| Shares Outstanding | 250.45M | 32.20M |
| Float Shares | N/A | 22.63M |
| % Held by Insiders | N/A | 0.10% |
| % Held by Institutions | N/A | 0.29% |
Dividend Analysis & Yield Comparison: KraneShares China vs Sagimet Biosciences
| Metric | KLIP | SGMT |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $36.04 | N/A |
| 3-Year Avg Dividend Yield | 12.98% | N/A |
| 3-Year Total Dividends | $108.11 | N/A |
| Ex-Dividend Date | Feb 27, 2024 | N/A |